Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) GF Value Rank : 2 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Sun-Novo Pharmaceutical Research Co GF Value Rank?

Beijing Sun-Novo Pharmaceutical Research Co has the GF Value Rank of 2.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank falls into.

Beijing Sun-Novo Pharmaceutical Research Co GF Value Rank Related Terms

Thank you for viewing the detailed overview of Beijing Sun-Novo Pharmaceutical Research Co's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sun-Novo Pharmaceutical Research Co Ltd (SHSE:688621) » Definitions » GF Value Rank

Traded in Other Exchanges

N/A

Address

No. 79 Shuangying West Road, 1st Floor, Building 7, Science Park, Changping District, Beijing, CHN, 102200

Website

http://www.sun-novo.com

Beijing Sun-Novo Pharmaceutical Research Co Ltd is engaged in providing professional research and development outsourcing services for pharmaceutical companies.

Executives

Shao Yan	Director
Zhao Ling Yang	Director
Liu Yu Jing	Directors, senior managers
Li Qian	Director

Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Headlines

No Headlines